Login / Signup

Prognostic Value of the 13 C-Methacetin Breath Test in Adults with Acute Liver Failure and Non-acetaminophen Acute Liver Injury.

Robert J FontanaR Todd StravitzValerie DurkalskiJames HanjeBilal HameedDavid KochAdrian ReubenDaniel GangerJody C OlsonIris LiouBrendan M McGuireKristen ClasenWilliam M Lee
Published in: Hepatology (Baltimore, Md.) (2022)
The 13 C-MBT is a promising tool to estimate the likelihood of hepatic recovery in patients with ALF and ALI. Use of the PDR peak data from the 13 C-MBT point-of-care test may assist with medical decision making and help avoid unnecessary transplantation in critically ill patients with ALF and ALI.
Keyphrases
  • liver failure
  • liver injury
  • drug induced
  • hepatitis b virus
  • decision making
  • healthcare
  • electronic health record
  • intensive care unit
  • stem cells
  • respiratory failure
  • machine learning
  • artificial intelligence